This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: I have several concerns about the study of Dr Buchbinder and colleagues.¹ First, the study enrolled patients who had only 6 weeks of symptoms, without a minimum baseline pain level requirement. By contrast, my study of the higher-energy device approved by the US Food and Drug Administration required symptoms of at least 6 months' duration with a minimum pain scale score criterion (G.H.T., unpublished data, 2002). The reason is that most cases of plantar fasciitis are self-limited and resolve within 6 to 8 months.

Second, the control group of this study was treated with low-energy EWST while the active group was treated with a higher dose. If both the placebo and active groups are exposed to the same treatment, the ability to differentiate and validate the results between the 2 groups becomes impaired.

Third, the study of Buchbinder et al used low-energy ESWT administered at 3 different . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Ultrasound-Guided Extracorporeal Shock Wave Therapy for Plantar Fasciitis: A Randomized Controlled Trial
, , , , , and
JAMA. ;288():1364-1372.
FULL TEXT  

Shock Wave Therapy for Treatment of Plantar Fasciitis

JAMA. ;289():172-172.
FULL TEXT  

Shock Wave Therapy for Treatment of Plantar Fasciitis

JAMA. ;289():172-172.
FULL TEXT  

Shock Wave Therapy for Treatment of Plantar Fasciitis
, , and
JAMA. ;289():172-173.
FULL TEXT